EMS (pharmaceuticals)
EMS is the biggest domestic pharmaceutical company in Brazil.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
EMS is the biggest domestic pharmaceutical company in Brazil. Founded in the mid-1950s, the company has six industrial plants based in São Bernardo do Campo, Hortolândia and Jaguariúna, in the state of São Paulo, Manaus, Brasília and Belgrade in Serbia. EMS operates through five divisions: * EMS Similars - markets similares; a class of pharmaceuticals peculiar to the Brazilian market.
Not generics but not original brands either; * EMS Generics - markets generics; * EMS Sigma Pharma - markets branded medicines; * EMS Hospital - markets drugs to hospitals; * EMS Consumer - markets OTC drugs. Today the company has a presence in over 30 countries through joint-ventures and strategic partnerships with other pharmaceutical companies.
EMS's Brazilian main competitors are Hypera Pharma, Eurofarma, Aché and Cristália.
EMS is the biggest domestic pharmaceutical company in Brazil. Founded in the mid-1950s, the company has six industrial plants based in São Bernardo do Campo, Hortolândia and Jaguariúna, in the state of São Paulo, Manaus, Brasília and Belgrade in Serbia. EMS operates through five divisions: EMS Similars - markets similares; a class of pharmaceuticals peculiar to the Brazilian market.
Not generics but not original brands either; EMS Generics - markets generics; EMS Sigma Pharma - markets branded medicines; EMS Hospital - markets drugs to hospitals; EMS Consumer - markets OTC drugs. Today the company has a presence in over 30 countries through joint-ventures and strategic partnerships with other pharmaceutical companies.
EMS's Brazilian main competitors are Hypera Pharma, Eurofarma, Aché and Cristália.
External links
Official website
Text derived from https://en.wikipedia.org/w/index.php?oldid=1363149139 under CC BY-SA 4.0; modifications have been made.